Overview of Фамотел

Property	Description
Active ingredient	Famotidine (Фамотидин)
Forms	Tablets, Film-coated tablets, Solutions for injection
Pharmacological class	Histamine H₂-receptor antagonist (H₂-блокатор)
General purpose	Managing gastric acid hypersecretion
Origin	Synthetic compound

Фамотел: Defining the Pharmacological Class and Substance

Фамотел is a medicinal preparation whose core active ingredient is Famotidine, a synthetic compound officially classified as a Histamine H₂-receptor antagonist or H₂-блокатор. The preparation utilizes Famotidine as a single active ingredient, concentrating its systemic therapeutic effect on one specific pathway. This classification is clinically recognized for defining agents that provide a targeted approach to managing conditions driven by excessive stomach acid, such as protecting the esophageal lining from irritation.

Famotidine is a competitive inhibitor that selectively binds to H₂-receptors, obstructing the actions mediated by histamine. Famotidine is generally used to reduce the amount of acid the stomach makes, which helps ease symptoms associated with too much stomach acid. Famotidine’s role is to prevent acid generation at its source, leading to a sustained and comprehensive suppression of gastric secretions.

Forms and General Purpose of Famotidine

Famotidine is manufactured in multiple pharmaceutical preparations to ensure flexibility in clinical settings. The main forms include oral solid forms, such as tablets and film-coated tablets, alongside specialized parenteral forms like lyophilized powder or solutions for intravenous (IV) injection. The provision of both an oral route and an IV route makes it a versatile agent, suitable for both standard management and acute clinical needs.

The core general purpose of Famotidine is its capacity to function as an antiulcer and gastrointestinal agent by managing conditions characterized by gastric hypersecretion. The primary, clinically important pharmacologic activity of Famotidine is the inhibition of gastric secretion. Famotidine reduces both the acid concentration and the overall volume of gastric output, providing a consistent mechanism for healing. This fundamental effect is essential for creating a low-acidity environment that facilitates the natural repair mechanisms in tissues irritated or damaged by corrosive gastric acid.

What side effects are possible with Фамотел?

Possible Side Effects and Safety Information

The official safety documentation for Famotidine, a histamine H₂-receptor antagonist, classifies potential adverse reactions based on frequency and system-organ class, providing a structured overview of the medicine’s regulatory risk profile. The following descriptions are derived strictly from government health authority labeling.

Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized in regulatory documents, with the most frequently observed events classified as Common (reported in 1% to 10% of patients). These commonly documented reactions include Headache, Dizziness, Constipation, and Diarrhoea. Less frequent, Uncommon reactions may involve abdominal discomfort, nausea, vomiting, or skin reactions such as rash and pruritus.

Serious Adverse Reactions and Systemic Concerns

Regulatory labeling identifies rare but clinically significant adverse reactions, which span several physiological systems. Serious adverse reactions specifically highlighted in official warnings include severe Hypersensitivity Reactions (such as Anaphylaxis) and serious Central Nervous System (CNS) adverse reactions like Confusion and Seizures. Other very rare but serious concerns officially documented involve potential Cardiac Disorders, such as QT prolongation, and severe skin reactions like Toxic Epidermal Necrolysis.

Population-Specific Safety Considerations

The regulatory profile specifies increased caution for certain patient populations. Individuals with Renal Impairment and older adults are noted to have an elevated risk for developing CNS adverse reactions due to altered drug clearance, mandating particular attention to potential systemic exposure. Furthermore, the label contraindicates the medicine in patients with a history of serious hypersensitivity reactions to Famotidine or other H₂-receptor antagonists.

Overdose and Emergency Response

The official regulatory documentation for Famotidine details specific clinical manifestations and mandated emergency actions in the event of an overdose. Documented presentations primarily involve the Central Nervous System (CNS) and Cardiovascular System. CNS effects reported include confusion, delirium, agitation, seizures, slurred speech, and excessive drowsiness. Cardiovascular concerns include abnormal heartbeat and hypotension (low blood pressure). The risk of serious outcomes such as QT prolongation is noted, particularly in elderly patients and those with renal impairment, due to elevated systemic drug levels.

In the event of a suspected overdose, regulatory guidance strictly requires the patient to seek medical help or contact a Poison Control Center right away. Emergency services must be contacted immediately if severe, life-threatening symptoms are present, such as collapse, seizure, trouble breathing, or inability to be awakened. Overdose management is limited to symptomatic and supportive treatment, as no specific antidote is known. This supportive approach includes continuous monitoring of vital signs and cardiac activity (ECG), as well as potential use of decontamination procedures like activated charcoal.

Therapeutic Uses of Фамотел

What Фамотел Treats: Main Uses and Benefits

Фамотел is commonly used across conditions presenting with acute episodes that may involve symptoms linked to organ-specific functional stress. It is relevant when supportive symptom management is appropriate, particularly for symptoms associated with acute or episodic changes, symptoms related to inflammatory or irritative states, and symptoms associated with acute or episodic changes. The medicine is primarily applied in addressing symptom clusters that may become intense or disruptive.

Supportive Management for Acute Discomfort

This domain addresses symptoms related to heightened physiological activity, which often appear suddenly. It is commonly used when short-term symptomatic assistance is needed. This provides support that helps ease the overall symptom burden and assists with maintaining functional stability. It plays a role in managing symptoms that create noticeable physiological strain.

Management of Episodic Symptom Patterns

The medicine is used in situations involving recurrent or episodic manifestations, applicable in contexts marked by increased discomfort or tension. It is relevant when symptoms become more disruptive during flare-ups, and the key benefit is that it contributes to improved comfort during periods of heightened symptoms by addressing symptoms that interfere with daily comfort. This supports patients during difficult episodes by easing distress.

Quick Fact: Symptomatic Assistance
Is commonly used to help with symptoms related to physical discomfort that can intensify temporarily.

Eligibility and Restrictions for Use

Official Eligibility Profile for Фамотел (Famotidine)

Regulatory authorities define eligibility for Famotidine through specific requirements concerning age, allergies, organ function, and physiological state. The medicine must not be used by patients with a history of serious hypersensitivity reactions to Famotidine or any other H₂-receptor antagonist. Tablet formulations are also contraindicated in individuals with certain hereditary disorders, such as Lapp lactase deficiency.

Population Group	Regulatory Eligibility Status
Adults	Generally Approved
Pediatric Patients	Approved from birth, with formulation restrictions; tablet use not recommended below 40 kg
Renal Impairment	Restricted Use: Requires dosage adjustment (e.g., CrCl < 60 mL/min)
Pregnancy	Conditional Use: Not recommended unless clearly needed (risk vs. benefit)
Lactation	Restricted Use: Requires discontinuation of either the drug or breastfeeding

Eligibility also requires the exclusion of gastric malignancy prior to use in patients presenting with ulcer symptoms, as symptomatic relief does not rule out cancer. Furthermore, the injectable form is not approved for neonates.

What should I know about interactions with other medicines?

The official interaction profile of Famotidine is defined by its effect on gastric pH, its clearance through metabolic or renal pathways, and physical adsorption. Specific interacting products explicitly listed in regulatory documents include Tizanidine, Probenecid, Sucralfate, Antacids, and several pH-dependent drugs such as Ketoconazole, Atazanavir, and certain Tyrosine Kinase Inhibitors (TKIs).

The primary mechanistic basis involves the inhibition of gastric acid secretion, which leads to a reduction in the systemic exposure of many co-administered medicines, potentially causing a loss of efficacy. For this reason, co-administration with specific TKIs is not recommended. Furthermore, Famotidine is documented to inhibit CYP1A2-mediated clearance of Tizanidine, leading to substantially increased blood concentrations, and the combination is advised to be avoided if possible. Concomitant use with Probenecid should also be avoided, as it delays Famotidine elimination.

Mandatory timing-based rules govern certain combinations. Famotidine must be taken one to two hours before Antacids, and co-administration with Sucralfate must be avoided within two hours. Similarly, Ketoconazole must be administered two hours before Famotidine. The interaction with alcohol (ethanol) is documented to have no effect on blood alcohol levels. Population-specific notes caution that patients with renal impairment have an increased risk of CNS adverse reactions and QT prolongation, attributed to slower Famotidine clearance.

The overall interaction structure is based on pharmacokinetic domains that establish specific, high-risk combinations that must be avoided and set mandatory timing rules for co-administration with pH-altering agents.

Mechanism of Action

Blocking the Acid-Stimulating Signal

The mechanism of action is defined by its role as a selective antagonist at the histamine H2 receptors. These receptors are expressed on the basolateral membrane of the parietal cells in the stomach lining. By competitively binding to these receptors, the drug blocks the ability of endogenous histamine to activate the cellular processes responsible for acid production. This peripheral mechanistic action dampens the signal transduction cascade within the parietal cell.

Physiological Consequence

The blockade of the H2 receptor leads to a reduction in the total number of activated H^+/ K^+-ATPase (proton pumps) on the cell's apical membrane. This systemic reduction in pump activity results in a substantial decrease in the secretion rate of hydrochloric acid (HCl) into the gastric lumen. This targeted modulation alters the chemical environment of the stomach, resulting in an elevation of the overall pH level.

Dosage and Administration Information

Administration Guidelines

Route and Timing

Фамотел is administered orally as a tablet, chewable tablet, or oral suspension. It may be taken with or without food. For certain conditions, the prescribed regimen may be once daily at bedtime or multiple times daily (e.g., twice daily) in the morning and at bedtime.

Dosage Administration Type	Instruction Requirement	Duration Limit
Oral Tablet	Swallow the tablet whole with water.	Prescription use: up to 8 or 12 weeks, depending on the condition.
Chewable Tablet	Chew thoroughly before swallowing.	OTC use: maximum of 14 continuous days unless directed otherwise.
Oral Suspension	Shake the bottle vigorously for 5 to 10 seconds before measuring the dose.

Official Dosing Rules

The standard oral dosage ranges from 10 mg to 40 mg, taken once or twice daily, as specified by the intended use. For pathological hypersecretory conditions, the initial dosage is 20 mg every six hours, which may be adjusted to a maximum of 160 mg every six hours, based on individual patient needs.

Special Patient Conditions

Dosage adjustments are recommended for adult patients with moderate to severe renal impairment (kidney problems), defined as a creatinine clearance less than 60 mL/min. To avoid drug accumulation, the dosage may be reduced by 50% or the dosing interval may be prolonged to 36 to 48 hours.

Missed Dose

If a dose is missed, the instructions advise taking the next dose at the regular scheduled time. Patients should not take a double dose to make up for the missed one.

Recent Clinical Evidence

Research evidence / Overview of studies for Фамотел (Famotidine)

Evidence for Use in Acute Peptic Ulcer Disease and Hypersecretory Conditions

The research exploring the use of Famotidine in conditions characterized by high stomach acid, such as duodenal and gastric ulcers, is based on decades of clinical investigation. This evidence includes Randomized Controlled Trials (RCTs) and systematic reviews. Studies monitored patient groups diagnosed with active ulcers to see how the inner lining of the stomach and duodenum evolved over time. Researchers also monitored the change in the volume and acidity of gastric secretions.

Studies were conducted during periods of increased symptom activity and monitored responses over defined time intervals, typically four to eight weeks. Research also explored the use of Famotidine in research contexts involving extreme gastric acid output seen in individuals with pathological hypersecretory conditions, such as Zollinger-Ellison Syndrome.

Evidence for Use in Gastroesophageal Reflux Disease (GERD) and Heartburn Relief

Research explored the use of Famotidine in studies examining patient-reported experiences related to Gastroesophageal Reflux Disease (GERD) and ordinary heartburn. This evidence comes from both prescription-focused and over-the-counter (OTC) regulated trials. The research included RCTs used in research exploring how symptoms change over time. These trials monitored how symptoms evolved in the observed populations, such as the frequency and intensity of heartburn and acid regurgitation.

For more severe conditions, such as erosive esophagitis (irritation of the food pipe), research monitored the endoscopic healing of the mucosal lining over defined treatment periods. However, some evidence suggests that the acid-reducing action may show a pattern of diminishing over time if the medicine is used continuously for several weeks. This pattern of tolerance was observed in some studies.

Research Gaps and Areas of Uncertainty

While the core research for the primary uses is established, gaps and uncertainties exist, particularly in newer, investigational areas. Studies recently conducted during periods of increased symptom activity, such as during outbreaks of acute viral illnesses, explored the use of Famotidine in an observational setting. The findings were mixed across these investigational studies, and consistency is uncertain. Certainty remains low, and research is ongoing to clarify any potential non-acid-related effects.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Фамотел (FAQ)

Q: Is Фамотел the same as other stomach acid reducers like [Name of competitor drug]?

According to official documents, Фамотел is classified as a Histamine H₂-receptor antagonist, sometimes called an H₂-blocker. This means it works by blocking a chemical signal that prompts the stomach to create acid. This is different from antacids, which neutralize existing acid, and also differs from other acid-reducing medications.

Q: Does Фамотел treat the actual cause of stomach problems or just the symptoms?

The official purpose of this medicine is to manage conditions characterized by high stomach acid output, a condition called gastric hypersecretion. By reducing the volume and concentration of acid, it helps ease the symptoms you feel. Creating a less acidic environment facilitates the natural repair mechanisms of tissues that may be damaged or irritated, such as in the case of ulcers.

Q: If I feel better, can I stop taking Фамотел suddenly?

For prescribed conditions, such as the treatment of ulcers, the medicine is typically taken for a specific period (e.g., 8 to 12 weeks). If the medicine is stopped before the prescribed duration is complete, there is a risk that the underlying condition or symptoms could return. Official guidance for over-the-counter use limits continuous use to a maximum of 14 days unless otherwise directed by a healthcare professional.

Q: Does the time of day I take Фамотел matter for its effectiveness?

Yes, the timing may matter depending on the reason for use. For treating some conditions, the prescription may specify taking it once daily at bedtime or multiple times throughout the day. When used for preventing anticipated heartburn, official guidance suggests taking the medicine a specified amount of time before consuming foods or drinks that typically cause symptoms.

Q: Can Фамотел be taken with common pain relievers like paracetamol or ibuprofen?

Official documents note that the active ingredient in Фамотел is available in combination with ibuprofen in certain prescription products to help reduce the gastrointestinal risk associated with that pain reliever. Official documents do not typically flag an interaction between this medicine and paracetamol (acetaminophen). Reviewing the full interaction profile is part of standard medical guidance.

Q: Are there any specific foods or drinks to avoid while taking Фамотел?

The official instructions state that the medicine can be taken with or without food, as food does not significantly impact its absorption. Official interaction studies have indicated no effect on blood levels of alcohol (ethanol). For individuals taking the medicine to treat or prevent heartburn, avoiding specific foods that trigger their symptoms may still be part of their overall management.

Q: How long does it typically take for Фамотел to start working? (Onset)

Studies and official information indicate that the acid-reducing effect of the medicine typically begins within one hour after the dose is taken. Its effect is sustained, unlike antacids which provide immediate but temporary relief.

Q: How long does the effect of one dose of Фамотел last? (Duration)

The duration of the medicine's effect, meaning how long it suppresses the production of stomach acid after a single dose, is at least nine hours. Depending on the prescribed dosage, this acid-reducing effect can last for up to 10 to 12 hours.

Q: Is it okay to take Фамотел every day for a long period?

Official guidelines for over-the-counter use limit continuous, everyday intake to a maximum of 14 days unless otherwise directed. When prescribed, long-term use is usually for defined periods, such as up to 12 weeks. Additionally, studies have noted a pattern of tolerance in some patients when the medicine is used continuously for several weeks.

Q: What does 'tolerance' mean when discussing Фамотел, and is it a concern?

In medical research, tolerance refers to a pattern where the initial acid-reducing effect of the medicine may show signs of diminishing over time if it is used continuously for several weeks. Official research has noted this pattern in some study populations.

Q: What is the difference between Фамотел and antacids?

Antacids function by directly neutralizing the stomach acid that has already been produced. Фамотел, in contrast, is an H₂-receptor antagonist, which means it acts to prevent stomach cells from producing and secreting the acid in the first place, offering a different approach to managing acid levels.

Q: Does Фамотел interact with supplements or vitamins?

The medicine works by reducing the overall amount of acid in the stomach. This reduction in acidity may potentially alter the absorption of any supplement or vitamin that requires an acidic environment to be fully absorbed.

Q: Can Фамотел be used by people who are breastfeeding?

Official eligibility criteria state that the use of this medicine is restricted for people who are breastfeeding. This restriction exists because small amounts of the active ingredient are known to pass into breast milk. Due to this restriction, official regulatory status requires the discontinuation of either the drug or the act of breastfeeding while undergoing treatment.

Q: What evidence exists about the effectiveness of Фамотел in children?

Official regulatory guidelines and dosing information have been established for pediatric patients, including infants from birth. Official documents include its use for treating conditions like Gastroesophageal Reflux Disease (GERD) and for stress ulcer prevention in children.

Q: Is it true that Фамотел can interact with blood thinners?

Yes, the official interaction profile includes a warning regarding the blood thinner Warfarin. Regulatory documents describe a potential interaction where this medicine may slow down the body's clearance of Warfarin, which could potentially increase the risk of bleeding.

Q: How is Фамотел used to treat a condition called Zollinger-Ellison syndrome?

Official research and prescribing information state that the medicine is used to manage and control the high output of gastric acid that is characteristic of Zollinger-Ellison syndrome. The dosage used for this condition is often distinct from the dosage used for other common conditions.

Q: Can Фамотел be used to prevent stomach upset from other medications?

Official documents note that this medicine is often prescribed or used in combination with other drug classes, such as Nonsteroidal Anti-inflammatory Drugs (NSAIDs). This combined use is intended to help prevent or reduce the associated gastrointestinal adverse events that the other medicine may cause.

Q: Does Фамотел carry a specific warning related to the liver?

The official safety documentation includes information on rare liver-related adverse reactions. These reactions have included observations of jaundice, intrahepatic cholestasis (a type of bile flow blockage in the liver), and elevated liver enzyme abnormalities.

Q: What happens if I take too much of this medicine?

Regulatory resources covering overdose for this class of medicine indicate that effects may include confusion, agitation, hallucinations, and drowsiness. If any symptoms suggestive of an overdose occur, official safety information indicates that medical attention is needed.

Q: What common non-prescription medicines are listed as having a potential interaction with Фамотел?

The official interaction profile includes mandatory timing rules for co-administration with antacids, which are widely available over-the-counter. The medicine is also often used in combination with common Nonsteroidal Anti-inflammatory Drugs (NSAIDs).

How should Фамотел be stored and disposed of?

Storage and Disposal Requirements for Famotidine (Фамотел)

Famotidine preparations must be stored and disposed of according to strict regulatory guidelines to maintain stability and safety.

Storage Conditions

Famotidine tablets and the oral suspension require storage at Controlled Room Temperature, between 20 C and 25 C (68 F and 77 F). The medicine must be protected from moisture.

Preparation	Specific Requirement
Oral Suspension	Store in the original container and keep the bottle tightly closed.
Injection Solution	Store below 25 C, protect from light, and do not freeze.
All Forms	Store out of the sight and reach of children.

Stability and Disposal

The reconstituted oral suspension is stable for 30 days at controlled room temperature and must be discarded thereafter. Unused or expired Famotidine must not be disposed of in wastewater or household trash; disposal must follow local pharmaceutical waste regulations.

Фамотел